Vienna, Austria

ESTRO 2023

Session Item

Saturday
May 13
15:15 - 16:15
Stolz 1
Prostate
Filippo Alongi, Italy;
William Kinnaird, United Kingdom
Mini-Oral
Clinical
Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation
Cesare Cozzarini, Italy
MO-0220

Abstract

Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation
Authors:

Maddalena Pavarini1, Luciana Rago2, Fernando Munoz3, Alessandro Magli4, Domenico Cante5, Giuseppe Girelli6, Andrea Bresolin1, Barbara Noris Chiorda7, Justyna Magdalena Waskiewicz8, Barbara Avuzzi7, Elisabetta Garibaldi9, Adriana Faiella10, Elisa Villa11, Paolo Ferrari12, Letizia Ferella3, Cristina Piva5, Teodora Statuto13, Marco Gatti14, Tiziana Rancati15, Riccardo Valdagni7, Vittorio Luigi Vavassori11, Giuseppe Sanguineti16, Nadia Gisella Di Muzio17, Claudio Fiorino1, Cesare Cozzarini17

1IRCCS San Raffaele Scientific Institute, Medical Physics, Milano, Italy; 2Ospedale San Carlo, Radiotherapy, Potenza, Italy; 3Ospedale Regionale Parini-AUSL Valle d’Aosta, Radiotherapy, Aosta, Italy; 4Azienda Ospedaliero Universitaria S. Maria della Misericordia, Radiotherapy, Udine, Italy; 5Ospedale di Ivrea, Radiotherapy, Ivrea, Italy; 6Ospedale degli Infermi, Radiotherapy, Biella, Italy; 7Fondazione IRCCS Istituto Nazionale dei Tumori, Radiotherapy, Milano, Italy; 8Comprensorio Sanitario di Bolzano, Radiotherapy, Bolzano, Italy; 9A.O. SS. Antonio e Biagio, Radiotherapy, Alessandria, Italy; 10Istituto Nazionale dei Tumori "Regina Elena", Radiotherapy, Roma, Italy; 11Cliniche Gavazzeni-Humanitas, Radiotherapy, Bergamo, Italy; 12Comprensorio Sanitario di Bolzano, Medical Physics, Bolzano, Italy; 13Ospedale San Carlo, Biology, Potenza, Italy; 14Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia IRCCS, Radiotherapy, Candiolo, Italy; 15Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milano, Italy; 16Istituto Nazionale dei Tumori "Regina Elena", Radiotherapy, Rome, Italy; 17IRCCS San Raffaele Scientific Institute, Radiotherapy, Milano, Italy

Show Affiliations
Purpose or Objective

To prospectively assess the impact of patient-reported intestinal toxicity (IT) on 2-year health-related quality of life (HRQoL) in a large multi-institute cohort of patients (pts) who underwent radiotherapy (RT) including pelvic nodal irradiation (PNI) for prostate cancer (PCa) with different intent.

Material and Methods

A prospective multi-Institute study aimed at evaluating IT after RT including PNI along with its detrimental impact on pts’ HRQoL recruited 886 between 2011 and 2021.

The Inflammatory Bowel Disease Questionnaire (IBDQ) was administered at baseline, at RT mid-point and end, at 3 and 6 months and thereafter every 6 months up to 5 years. IBDQ items analyze four Domains, that of Bowel symptoms (BOWEL) and their impact on Emotional (EMOT), Social (SOCIAL) and Systemic (SYST) aspects of HRQoL.

The 554 pts considered for the current analysis had complete baseline, 2-years and both RT mid-point and end RT (90%) questionnaires or at least one between RT mid-point and end (10%). The differences between baseline and 2-year single Bowel items (n=10) and Domain scores were investigated, accounting for the BOWEL baseline and Worst (defined as the largest BOWEL worsening between baseline and RT mid-point or end). Monotonic relationships between 2-year variations of single BOWEL items and EMOT, SOCIAL and SYST were also investigated to quantitatively assess the 2-year bowel symptoms mostly related to HRQoL worsening, through the Spearman’s rho coefficient.

Results

The distributions of the differences between each IBDQ Domain score at baseline and at 2 years were tested via the Wilcoxon signed-rank test. Differences were found to be significant for three out of four Domains: EMOT completely recovered within 2 years from RT end (p=0.42), while the others did not (p<0.001). BOWEL baseline values did not impact the deterioration of BOWEL and SYST; on the contrary, baseline values below and above the first quartile (Q1) resulted in stable  impaired SOCIAL scores, respectively. Instead, patients with lower Worst values (Q1 did not show significant worsening: this result suggests that the intensity of acute bowel symptoms is associated to a degradation of the 2-year SOCIAL domain.

Spearman's rho coefficients suggest that the bowel symptoms related to “Urge to Go to Bathroom” (IBDQ24, ρ= 0.31-0.39), “Accidental Soiling” (IBDQ26, ρ= 0.28-0.37), “Gas Passage” (IBDQ17, ρ= 0.24-0.34) and “Abdominal Bloating” (IBDQ20, ρ= 0.26-0.34) were the ones more associated to individual deterioration of EMOT, SOCIAL and SYST.



Conclusion

Bowel symptoms and Bowel associated 2-year HRQoL were significantly worsened for SOCIAL and SYST domains while EMOT did not change. The severity of acute bowel symptoms were associated to the degradation of SOCIAL domain. Specific intestinal symptoms at 2 years were associated to 2-year EMOT, SOCIAL and SYST decline with respect to baseline.